{
  "figure_1": "(A) Proportion of chemotherapy-related neutropenia, (B) patients who had more than one episode of neutropenia, (C) disease type, and (D) sex. LPD, lymphoproliferative disorder; PCD, plasma cell disorder.",
  "figure_2": "Age distribution in (A) chemotherapy-induced and disease-induced neutropenia, (B) chemotherapy-induced neutropenic sepsis and no sepsis, (C) chemotherapy-induced and disease-induced sepsis, and (D) duration in days from chemotherapy to neutropenic sepsis and neutropenia. CIN, chemotherapy-induced neutropenia; CINS, chemotherapy-induced neutropenic sepsis; DIN, disease-induced neutropenia; DINS, disease-induced neutropenic sepsis.",
  "figure_3": "(A) Neutrophil count, (B) hemoglobin, (C) platelet count, and (D) duration of neutropenia in the chemotherapy-induced neutropenic sepsis group compared with the nonseptic group. CIN, chemotherapy-induced neutropenia; CINS, chemotherapy-induced neutropenic sepsis.",
  "figure_4": "(A) TTA; (B) time to start antibiotics during daytime, night-time, and weekends; (C) CRP; (D) duration of antibiotics; (E) duration of colony-stimulating factors, and (F) duration of hospital stay in the CINS group compared with the DINS group. CINS, chemotherapy-induced neutropenic sepsis; CRP, C-reactive protein; CSF, colony stimulating factors; DINS, disease-induced neutropenic sepsis; M-F, Monday to Friday; S-S, Saturday to Sunday; TTA, time to antibiotics from admission or from time of sepsis."
}